Deals
Carlyle to Buy Vitamin Maker NBTY for $3.8 Billion
This article is for subscribers only.
Carlyle Group agreed to acquire NBTY Inc., the maker of Nature’s Bounty, MET-Rx and Solgar nutritional supplements, for $3.8 billion in the biggest leveraged buyout this year.
NBTY rose $16.24, or 43 percent, to $53.71 by 2:45 p.m. in New York Stock Exchange composite trading after saying in a statement that Carlyle offered to pay $55 a share in cash for the Ronkonkoma, New York-based company. The offer is 47 percent higher than yesterday’s closing price.